Median survival for metastatic gastric cancers were 108.71 days (range 15 - 270 days), for pancreatic head cancers were 80.71 days (range 2 - 165 days), for CBD cancers were 159.5 days (range 45 - 274 days), for invasive gallblader cancers were 141.75 days (range 31 - 315 days) and for hepatic hilar cancers were 111.69 ñdays (range 21 - 195 days). Complication: epigastric pain 100%, fever and chills 44.61%, hemobilia 3.1%, leaking around catheter 20.75%, catheter dislodgment 24.52%, obstructed catheter 26.41%, fluid and electrolyte losses were trivial (p>0.005), mortality rate was 1.5%.